Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
Mark J SarnakRajiv AgarwalNeil BoudvillePradip C P ChowdhuryKai Uwe EckardtCarlos R GonzalezLaura A KooiengaMark J KouryKwabena A NtosoWenli LuoPatrick S ParfreyDennis L VargoWolfgang C WinkelmayerZhiqun ZhangGlenn M ChertowPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
In the subgroup of patients receiving peritoneal dialysis in the phase 3 INNO2VATE trials, safety and efficacy of vadadustat were similar to darbepoetin alfa.